MedTrace Logo

Work Package 3 Education for ICU Clinicians in Basic Palliative Care

NCT06425692 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2024-05-22

No results posted yet for this study

Summary

The EPIC project aims at sustainably improving palliative care for seriously ill patients and their families in ICUs. To this aim, an interdisciplinary consortium is working together to provide a new practical palliative care model using telemedicine. The project is the first European intervention study on palliative care in the ICU using a systems- based approach with proactive patient identification, checklist and blended learning designed to meet the specific needs of ICU staff.

EPIC's vision is to contribute to a change in awareness from a narrow focus on prolonging life to a more holistic approach to care.

The development of blended learning for intensive care staff is the task of Work Package (WP) 3. The aim is to improve the attitude, understanding and self-confidence of ICU staff. Blended learning is to be developed and implemented for this purpose. The aim is to teach the basics of palliative care on a cognitive, affective and psychomotor level.

Due to the international character of the project, it is to be developed in English with subtitles in the local languages. In addition a workshop with patient and family advisors will be conducted.

Conditions

  • ICU
  • Staff Attitude
  • Learning
  • Palliative Care, Patient Care

Interventions

BEHAVIORAL

Education

Education on basic palliative care via e-learning + webinar to deepen knowledge.

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2028-03-01
Completion
2029-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06425692 on ClinicalTrials.gov